Hang Quach
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments 173
- Oncology top 2%
- Peptidase Inhibition and Analysis 42
- Cancer Treatment and Pharmacology 26
- CAR-T cell therapy research 20
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 25
- Immunology top 5%
- Molecular Biology top 5%
- Protein Degradation and Inhibitors 76
-
- Monoclonal and Polyclonal Antibodies Research 24
-
- HIV/AIDS drug development and treatment 18
- Co-authors
- Simon J. HarrisonH. Miles PrinceDavid RitchiePaul J. NeesonMark J. SmythA. Keith StewartXavier LeleuMaría‐Victoria Mateos
- Cited by
- HematologyOncologyGenetics
- Journals
- Blood (69 papers)Journal of Clinical Oncology (35 papers)British Journal of Haematology (7 papers)
- Partner nations
- AustraliaUnited StatesSpain
In The Last Decade
Hang Quach
186 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Hematology 1.8k
- Oncology 1.4k
- Genetics 343
- Immunology 534
- Molecular Biology 1.4k
Countries citing papers authored by Hang Quach
This map shows the geographic impact of Hang Quach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hang Quach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hang Quach more than expected).
Fields of papers citing papers by Hang Quach
This network shows the impact of papers produced by Hang Quach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hang Quach. The network helps show where Hang Quach may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hang Quach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 2 | |
| 13 | 2022 | 8 | |
| 14 | 2021 | 2 | |
| 15 | 2021 | 24 | |
| 16 | 2020 | 12 | |
| 17 | 2020 | 53 | |
| 18 | 2020 | 8 | |
| 19 | 2018 | 77 | |
| 20 | 2017 | 1 |
About Hang Quach
Hang Quach is a scholar working on Hematology, Oncology, Genetics, Molecular Biology and Pathology and Forensic Medicine, having authored 209 papers that have together received 2.6k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (173 papers), Protein Degradation and Inhibitors (76 papers), Peptidase Inhibition and Analysis (42 papers), Cancer Treatment and Pharmacology (26 papers), Chronic Lymphocytic Leukemia Research (25 papers), Monoclonal and Polyclonal Antibodies Research (24 papers), CAR-T cell therapy research (20 papers) and HIV/AIDS drug development and treatment (18 papers). The work is most often cited by research in Hematology (1.8k citations), Oncology (1.4k citations), Genetics (343 citations), Immunology (534 citations) and Molecular Biology (1.4k citations). Hang Quach has collaborated with scholars based in Australia, United States and Spain. Frequent co-authors include Simon J. Harrison, H. Miles Prince, David Ritchie, Paul J. Neeson, Mark J. Smyth, A. Keith Stewart, Xavier Leleu, María‐Victoria Mateos, Meletios Α. Dimopoulos and Katja Weisel. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, HemaSphere and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.